American Association for Cancer Research/X
Jan 29, 2025, 12:09
AACR – A Therapeutic HPV Vaccine Could Eliminate Precancerous Cervical Lesions
American Association for Cancer Research shared a post on LinkedIn:
“When patients with high-grade cervical precancers received a therapeutic HPV vaccine, half experienced clinical regression and 94% experienced lesion shrinkage, with most reductions evident within a month of vaccination, according to a study published in the AACR Journals Clinical Cancer Research. Learn more.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 26, 2025, 07:17
Feb 26, 2025, 07:09
Feb 26, 2025, 06:58
Feb 26, 2025, 06:49
Feb 26, 2025, 06:00
Feb 25, 2025, 16:56
Feb 25, 2025, 15:10
Feb 25, 2025, 14:12
Feb 25, 2025, 14:04